Remus Pharmaceuticals (NSE:REMUS) Long-Term Debt : ₹37 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Long-Term Debt?

Remus Pharmaceuticals's Long-Term Debt for the quarter that ended in Sep. 2024 was ₹37 Mil.

Remus Pharmaceuticals's quarterly Long-Term Debt increased from Sep. 2023 (₹14 Mil) to Mar. 2024 (₹30 Mil) and increased from Mar. 2024 (₹30 Mil) to Sep. 2024 (₹37 Mil).

Remus Pharmaceuticals's annual Long-Term Debt declined from Mar. 2021 (₹2 Mil) to Mar. 2022 (₹1 Mil) but then increased from Mar. 2022 (₹1 Mil) to Mar. 2024 (₹30 Mil).

Remus Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Remus Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Long-Term Debt Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Long-Term Debt

2.79

1.92

0.99

29.95

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24
Long-Term Debt	Get a 7-Day Free Trial			1.92	0.99	14.41	29.95	37.24

Remus Pharmaceuticals (NSE:REMUS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Remus Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines